Global law firm White & Case LLP has advised Pelion S.A. on an equity investment from the European Bank for Reconstruction and Development (EBRD) via a capital increase in Pelion, as a result of which the EBRD will become a minority shareholder in the company.
The EBRD investment will help Pelion, Poland's largest healthcare company which provides pharmaceutical distribution services to individual patients, pharmacies, hospitals and manufacturers, further strengthen its position in the Polish and European pharmaceutical market and explore and develop new business opportunities.
The White & Case team that advised on the transaction included partners Marcin Studniarek (Warsaw) and Ian Ivory (London), local partner Aneta Hajska (Warsaw) and associate Damian Lubocki (Warsaw).
Press contact
For more information please speak to your local media contact.
